BIOMAT Database Logo BIOMAT Database Logo

Differences in the therapeutic response of chlamydia-positive and chlamydia-negative forms of nongonococcal urethritis. 1976

H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes

UI MeSH Term Description Entries
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002689 Chlamydia A genus of the family CHLAMYDIACEAE whose species cause a variety of diseases in vertebrates including humans, mice, and swine. Chlamydia species are gram-negative and produce glycogen. The type species is CHLAMYDIA TRACHOMATIS.
D002690 Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA. Infections, Chlamydia,Chlamydia Infection,Infection, Chlamydia
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013754 Tetracyclines Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)

Related Publications

H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
Rosaramicin and tetracycline treatment in Chlamydia trachomatis-positive and -negative nongonococcal urethritis.
January 1981, Sexually transmitted diseases,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
Nongonococcal urethritis: the role of Chlamydia trachomatis.
March 1977, Annals of internal medicine,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
Oral sex as a risk factor for Chlamydia-negative ureaplasma-negative nongonococcal urethritis.
January 1988, Sexually transmitted diseases,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
Treatment of Chlamydia-positive and Chlamydia-negative nonspecific and postgonococcal urethritis.
December 1978, Annals of clinical research,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
Chlamydia trachomatis-induced urethritis in female partners of men with nongonococcal urethritis.
January 1979, Sexually transmitted diseases,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
[Importance of Chlamydia trachomatis in the etiology of nongonococcal urethritis].
November 1980, La Clinica terapeutica,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
[Direct immunofluorescence technique in the diagnosis of Chlamydia nongonococcal urethritis].
January 1989, Srpski arhiv za celokupno lekarstvo,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
Tosufloxacin in the treatment of nongonococcal urethritis, including Chlamydia trachomatis.
January 1994, Clinical therapeutics,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis.
October 1986, Antimicrobial agents and chemotherapy,
H H Handsfield, and E R Alexander, and S Pin Wang, and A H Pedersen, and K K Holmes
Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms.
June 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Copied contents to your clipboard!